ACR
ACRUX LIMITED
$0.0090
0.00%
Market cap
$5M
Turnover
$945
Last price
$0.0090
Day change
0.00%
Announcements
13
Range, past year
Open 0.014 · Low 0.009 · Now 0.009 · High 0.027
Open ACR in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
ACR momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
13/100
Wyckoff phase
Downtrend6d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
+0.0%
1 Month
-10.0%
1 Year
-35.7%
RSI
37
Avg daily range
4.4%
ACRUX LIMITED scores 13 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -30.8%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsACR announcements
Recent price-sensitive releases.
- 2026-08-26 FY26 Annual Report and Appendix 4E Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-08-06 Investor Presentation - Female Testosterone for HSDD Company Presentation
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-05-29 Update - Licensing Lenzetto for Australia for AUD5.4m
- 2026-05-28 Acrux licenses Lenzetto for Australian market for AUD5.4m
- 2026-05-14 Capital Gains Tax exemptions remain in place for Acrux
- 2026-05-11 Acrux raises $1.6 million via Share Placement
More Health Care stocks
Most traded in the same sector.